Effects of rosiglitazone and high fat diet on lipase/esterase expression in adipose tissue

Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids

Volumn 1771, Issue 2, 2007, Pages 177-184

  Shen, Wen Jun ^a   Patel, Shailja ^a   Yu, Zaixin ^a   Jue, Dyron ^a   Kraemer, Fredric B ^a  

^a VA PALO ALTO HEALTH CARE SYSTEM   (United States)

Author keywords

Esterase; High fat diet; Lipase; Rosiglitazone

Indexed keywords

ESTERASE; MESSENGER RNA; ROSIGLITAZONE; TRIACYLGLYCEROL LIPASE;

ADIPOSE TISSUE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME REGULATION; IMMUNOREACTIVITY; LIPID DIET; LIPOLYSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADIPOSE TISSUE, WHITE; ANIMALS; CARBOXYLIC ESTER HYDROLASES; CHOLESTEROL ESTERASE; DIETARY FATS; ESTERASES; FEMALE; GENE EXPRESSION; HYPOGLYCEMIC AGENTS; LIPASE; MICE; MICE, KNOCKOUT; MOLECULAR SEQUENCE DATA; THIAZOLIDINEDIONES;

MUS;

EID: 33846796185     PISSN: 13881981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbalip.2006.11.009     Document Type: Article

References (46)

1. Large V., Reynisdottir S., Langin D., Fredby K., Klannemark M., Holm C., and Arner P. Decreased expression and function of adipocyte hormone-sensitive lipase in subcutaneous fat cells of obese subjects. J. Lipid Res. 40 (1999) 2059-2066
2. Langin D., Dicker A., Tavernier G., Hoffstedt J., Mairal A., Ryden M., Arner E., Sicard A., Jenkins C., Viguerie N., van Harmelen V., Gross R., Holm C., and Arner P. Adipocyte lipases and defect of lipolysis in human obesity. Diabetes 54 (2005) 3190-3197
3. Londos C., Brasaemle D.L., Schultz C.J., Adler-Wailes D.C., Levin D.M., Kimmel A.R., and Rondinone C.M. On the control of lipolysis in adipocytes. Ann. N. Y. Acad. Sci. 892 (1999) 155-168
4. Holm C., Osterlund T., Laurell H., and Contreras J. Molecular mechanisms regulating hormone-sensitive lipase and lipolysis. Annu. Rev. Nutr. 20 (2000) 365-393
5. Kraemer F., and Shen W.-J. Hormone-sensitive lipase: control of intracellular tri-(di-) acylglycerol and cholesteryl ester hydrolysis. J. Lipid Res. 43 (2002) 1585-1594
6. Osuga J., Ishibashi S., Oka T., Yagyu H., Tozawa R., Fujimoto A., Shionoiri F., Yahagi N., Kraemer F., Tsutsumi O., and Yamada N. Targeted disruption of hormone-sensitive lipase results in male sterility and adipocyte hypertrophy, but not in obesity. Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 787-792
7. Jenkins C., Mancuso D., Yan W., Sims H., Gibson B., and Gross R. Identification, cloning, expression, and purification of three novel human calcium-independent phospholipase A2 family members possessing triacylglycerol lipase and acylglycerol transacylase activities. J. Biol. Chem. 279 (2004) 48968-48975
8. Zimmermann R., Strauss J., Haemmerle G., Schoiswohl G., Birner-Gruenberger R., Riederer M., Lass A., Neuberger G., Eisenhaber F., Hermetter A., and Zechner R. Fat mobilization in adipose tissue is promoted by adipose triglyceride lipase. Science 306 (2004) 1383-1386
9. Villena J., Roy S., Sarkadi-Nagy E., Kim K., and Sul H. Desnutrin, an adipocyte gene encoding a novel patatin domain-containing protein, is induced by fasting and glucocorticoids: ectopic expression of desnutrin increases triglyceride hydrolysis. J. Biol. Chem. 279 (2004) 47066-47075
10. Zechner R., Strauss J., Haemmerle G., Lass A., and Zimmermann R. Lipolysis: pathway under construction. Curr. Opin. Lipidol. 16 (2005) 333-340
11. Dolinksky V., Sipione S., Lehner R., and Vance D. The cloning and expression of a murine tracylglycerol hydrolase cDNA and the structure of its corresponding gene. Biochim. Biophys. Acta 1532 (2001) 162-172
12. Karlsson M., Contreras J., Hellman U., Tornqvist H., and Holm C. cDNA cloning, tissue distribution, and identification of the catalytic triad of monoglyceride lipase. Evolutionary relationship to esterases, lysophospholipases, and haloperoxidases. J. Biol. Chem. 272 (1997) 27218-27223
13. Birner-Gruenberger R., Susani-Etzerodt H., Waldhuber M., Riesenhuber G., Schmidinger H., Rechberger G., Kollroser M., Strauss J., Lass A., Zimmermann R., Haemmerle G., Zechner R., and Hermetter A. The lipolytic proteome of mouse adipose tissue. Mol. Cell. Proteomics 4 (2005) 1710-1717
14. Dumasia R., Eagle K., Kline-Rogers E., May C.L., and Mukherjee N.D. Role of PPAR-g agonist thiazolidinediones in treatment of pre-diabetic and diabetic individuals: a cardiovascular perspective. Curr. Drug Tragets, Cardiovasc. Haematol. Disord. 5 (2005) 377-386
15. Wilson T.M., Brown P.J., Sternbach D.D., and Henke B.R. The PPARs: from orphan receptors to drug discovery. J. Med. Chem. 43 (2000) 527-550
16. Kageyama H., Hirano T., Okada K., Ebara T., Kageyama A., Murakami T., Shioda S., and Adachi M. Lipoprotein lipase mRNA in white adipose tissue but not in skeletal muscle is increased by pioglitazone through PPAR-gamma. Biochem. Biophys. Res. Commun. 305 (2003) 22-27
17. Deng T., Shan S., Li P.P., Shen Z.F., Lu X.P., Cheng J., and Ning Z.Q. Peroxisome proliferator-activated receptor-gamma transcriptionally up-regulates hormone-sensitive lipase via the involvement of specificity protein-1. Endocrinology 147 (2006) 875-884
18. Kim J.Y., Tillison K., Lee J.H., Rearick D.A., and Smas C.M. The adipose tissue triglyceride lipase ATGL/PNPLA2 is downregulated by insulin and TNF-alpha in 3T3-L1 adipocytes and is a target for transactivation by PPARgamma. Am. J. Physiol.: Endocrinol. Metab. 291 (2006) E115-E127
19. Dalen K., Schoonjans K., Ulven S., Weedon-Fekjaer M., Bentzen T., Koutnikova H., Auwerx J., and Nebb H. Adipose tissue expression of the lipid droplet-associating proteins S3-12 and perilipin is controlled by peroxisome proliferator-activated receptor-gamma. Diabetes 53 (2004) 1243-1252
20. Watkins S.M., Reifsnyder P.R., Pan H.J., German J.B., and Leiter E.H. Lipid metabolome-wide effects of the PPARgamma agonist rosiglitazone. J. Lipid Res. 43 (2002) 1809-1817
21. Harada K., Shen W.-J., Patel S., Natu V., Wang J., Osuga J., Ishibashi S., and Kraemer F. Resistance to high fat diet-induced obesity associated with altered expression of adipose specific genes in hormone-sensitive lipase deficient mice. Am. J. Physiol.: Endocrinol. Metab. 285 (2003) E1182
22. Clifford G., Londos C., Kraemer F., Vernon R., and Yeaman S. Translocation of hormone-sensitive lipase and perilipin upon lipolytic stimulation of rat adipocytes. J. Biol. Chem. 275 (2000) 5011-5015
23. He J., Jiang H., Tansey J.T., Tang C., Pu S., and X.G. Calyculin and okadaic acid promote perilipin phosphorylation and increase lipolysis in primary rat adipocytes. Biochim. Biophys. Acta 1761 (2006) 247-255
24. Shen W.-J., Patel S., Natu V., and Kraemer F. Mutational analysis of structural features of rat hormone-sensitive lipase. Biochemistry 37 (1998) 8973-8979
25. Lake A., Sun Y., Li J., Kim J., Johnson J., Li D., Revett T., Shih H., Liu W., Paulsen J., and Gimeno R. Expression, regulation, and triglyceride hydrolase activity of Adiponutrin family members. J. Lipid Res. 46 (2005) 2477-2487
26. Dolinsky V., Gilham D., Alam M., Vance D., and Lehner R. Triacylglycerol hydrolase: role in intracellular lipid metabolism. Cell. Mol. Life Sci. 61 (2004) 1633-1651
27. Soni K., Lehner R., Metalnikov P., O'Donnell P., Semache M., Gao W., Ashman K., Pshezhetsky A., and Mitchell G. Carboxylesterase 3 (EC 3.1.1.1) is a major adipocyte lipase. J. Biol. Chem. 279 (2004) 40683-40689
28. Lefevre C., Jobard F., Caux F., Bouadjar B., Karaduman A., Heilig R., Lakhdar H., Wollenberg A., Verret J.L., Weissenbach J., Ozguc M., Lathrop M., Prud'homme J.F., and Fischer J. Mutations in CGI-58, the gene encoding a new protein of the esterase/lipase/thioesterase subfamily, in Chanarin-Dorfman syndrome. Am. J. Hum. Genet. 69 (2001) 1002-1012
29. Kadner S., Katz J., and Finlay T. Esterase-1: developmental expression in the mouse and distribution of related proteins in other species. Arch. Biochem. Biophys. 296 (1992) 435-441
30. Peters J., and Nash H. Esterases of Mus musculus: substrate and inhibition characteristics, new isozymes, and homologies with man. Biochem. Genet. 16 (1978) 553-569
31. Su X., Mancuso D., Bickel P., Jenkins C., and Gross R. Small interfering RNA knockdown of calcium-independent phospholipases A2 beta or gamma inhibits the hormone-induced differentiation of 3T3-L1 preadipocytes. J. Biol. Chem. 279 (2004) 21740-21748
32. Larsen T., Toubro S., and Astrup A. PPARgamma agonists in the treatment of type II diabetes: is increased fatness commensurate with long-term efficacy?. Int. J. Obes. Relat. Metab. Disord. 27 (2003) 147-161
33. Yamauchi T., Kamon J., Waki H., Murakami K., Motojima K., Komeda K., Ide T., Kubota N., Terauchi Y., Tobe K., Miki H., Tsuchida A., Akanuma Y., Nagai R., Kimura S., and Kadowaki T. The mechanisms by which both heterozygous peroxisome proliferator-activated receptor gamma (PPARgamma) deficiency and PPARgamma agonist improve insulin resistance. J. Biol. Chem. 276 (2001) 41245-41254
34. de Souza C., Eckhardt M., Gagen K., Dong M., Chen W., Laurent D., and Burkey B. Effects of pioglitazone on adipose tissue remodeling within the setting of obesity and insulin resistance. Diabetes 50 (2001) 1863-1871
35. Srebrnik A., Brenner S., Ilie B., and Messer G. Dorfman-Chanarin syndrome: morphologic studies and presentation of new cases. Am. J. Dermatopathol. 20 (1998) 79-85
36. Igal R.A., Rhoads J.M., and Coleman R.A. Neutral lipid storage disease with fatty liver and cholestasis. J. Pediatr. Gastroenterol. Nutr. 25 (1997) 541-547
37. Yamaguchi T., Omatsu N., Matsushita S., and Osumi T. CGI-58 interacts with perilipin and is localized to lipid droplets. Possible involvement of CGI-58 mislocalization in Chanarin-Dorfman syndrome. J. Biol. Chem. 279 (2004) 30490-30497
38. Subramanian V., Rothenberg A., Gomez C., Cohen A., Garcia A., Bhattacharyya S., Shapiro L., Dolios G., Wang R., Lisanti M., and Brasaemle D. Perilipin A mediates the reversible binding of CGI-58 to lipid droplets in 3T3-L1 adipocytes. J. Biol. Chem. 279 (2004) 42062-42071
39. Lass A., Zimmermann R., Haemmerle G., Riederer M., Schoiswohl G., Schweiger M., Kienesberger P., Strauss J., Orkiewicz G., and Zechner R. Adipose triglyceride lipase-mediated lipolysis of cellular fat stores is activated by CGI-58 and defective in Chanarin-Dorfman Syndrome. Cell Metab. 3 (2006) 309-319
40. Dolinsky V., Gilham D., Hatch G., Agellon L., Lehner R., and Vance D. Regulation of triacylglycerol hydrolase expression by dietary fatty acids and peroxisomal proliferator-activated receptors. Biochim. Biophys. Acta 1635 (2003) 20-28
41. Baulande S., Lasnier F., Lucas M., and Pairault J. Adiponutrin, a transmembrane protein corresponding to a novel dietary- and obesity-linked mRNA specifically expressed in the adipose lineage. J. Biol. Chem. 276 (2001) 33336-33344
42. Polson D., and Thompson M. Adiponutrin gene expression in 3T3-L1 adipocytes is downregulated by troglitazone. Horm. Metab. Res. 35 (2003) 508-510
43. Sztalryd C., Xu G., Dorward H., Tansey J., Contreras J., Kimmel A., and Londos C. Perilipin A is essential for the translocation of hormone-sensitive lipase during lipolytic activation. J. Cell Biol. 161 (2003) 1093-1103
44. Zhang H., Souza S., Muliro K., Kraemer F., Obin M., and Greenberg A. Lipase-selective functional domains of perilipin A differentially regulate constitutive and protein kinase A-stimulated lipolysis. J. Biol. Chem. 278 (2003) 51535-51542
45. Miyoshi H., Souza S.C., Zhang H.H., Strissel K.J., Christoffolete M.A., Kovsan J., Rudich A., Kraemer F.B., Bianco A.C., Obin M.S., and Greenberg A.S. Perilipin promotes hormone-sensitive lipase-mediated adipocyte lipolysis via phosphorylation-dependent and -independent mechanisms. J. Biol. Chem. 281 (2006) 15837-15844 (Epub 2006 Apr 4)
46. Haemmerle G., Lass A., Zimmermann R., Gorkiewicz G., Meyer C., Rozman J., Heldmaier G., Maier R., Theussl C., Eder S., Kratky D., Wagner E., Klingenspor M., Hoefler G., and Zechner R. Defective lipolysis and altered energy metabolism in mice lacking adipose triglyceride lipase. Science 312 (2006) 734-737